Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.